Healthcare Success

JULY 5, 2022

(Editor’s Note: I wrote the first version of this blog post back in 2006 when we launched Healthcare Success. Every time I run into someone who is faced with the daunting challenge of marketing to doctors or other healthcare professionals, I giggle empathetically and say, “I feel your pain.”. Conclusion.

Doctors 57

Doctors Physicians Marketing Healthcare 57

Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Healthcare Success

NOVEMBER 17, 2023

Did your business neglect to establish proper healthcare branding from the beginning? Most brands evolve every three to ten years, but healthcare rebranding doesn’t have to be scary or daunting. Today’s healthcare businesses face new and aggressive competition on multiple fronts.

Healthcare 73

Healthcare Healthcare Marketing Media 73

Healthcare Success

FEBRUARY 21, 2023

Content comes in levels or tiers, and your healthcare website requires the highest level. Writing high-quality content for healthcare that ranks high on Google and drives consumer action is hard. Along with damaging your reputation among consumers and peers, it goes against Google’s quality standards for healthcare content.

Healthcare 52

Healthcare Healthcare Marketing Specialization 52

Healthcare Success

APRIL 20, 2023

At Healthcare Success, we have been sharing marketing knowledge, tips, and tricks since our agency’s founding in 2006. Start With Some Classics Whether you’re a new marketer or a seasoned professional, take a deep dive into essential topics that can significantly impact your healthcare business.

Healthcare 52

Healthcare Healthcare Marketing Media 52

Clarivate

AUGUST 28, 2024

The continued strength of HUMIRA in France is particularly remarkable, Parisi noted, given that biosimilars are better entrenched in Europe, where a biosimilar was first approved in 2006. physicians tend to favor the tried-and true. In the U.S., In the U.S., However, in Europe as in the U.S.,

Prescription 59

Prescription Marketing Patients Physicians 59

European Pharmaceutical Review

SEPTEMBER 21, 2023

The impact of a one-time gene therapy treatment on national health budgets must also be considered, particularly at a time when many healthcare systems are facing financial challenges. Economic uncertainties can therefore lie in the high cost involved in drug development, manufacturing and delivery.

Pharmaceutical 96

Pharmaceutical Food and Drug Administration Medicine Patients 96